Evidence map›Paper›PMID 29387656›Full record

ArticleJournal of molecular biochemistry2017

HCV genetics and genotypes dictate future antiviral strategies.

Louis Papageorgiou, Chrisanthy Vlachakis, Konstantina Dragoumani, Sofia Raftopoulou, Dimitrios Brouzas, Nicolas C Nicolaides, George P Chrousos, Evangelia Charmandari, Vasileios Megalooikonomou, Dimitrios Vlachakis

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Journal of molecular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Louis PapageorgiouDepartment of Informatics and Telecommunications, National and Kapodistrian University of Athens, University Campus, Athens 15784, Greece.
Chrisanthy VlachakisClinical Dietitian-Nutritionist, PhD, Harokopio University, Kallithea, Attica, Greece.
Konstantina DragoumaniClinical Dietitian-Nutritionist, PhD, Harokopio University, Kallithea, Attica, Greece.
Sofia RaftopoulouSotiria Chest Diseases Hospital,152, Mesogion Av., Athens 11527, Greece.
Dimitrios Brouzas1 Department of Ophthalmology, University of Athens, 154, Mesogion Street, Athens 11527, Greece.
Nicolas C NicolaidesDivision of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
George P ChrousosDivision of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Evangelia CharmandariDivision of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Vasileios MegalooikonomouComputer Engineering and Informatics Department, School of Engineering, University of Patras, Patras 26500, Greece.
Dimitrios VlachakisDivision of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GRBiomedical Research Foundation of the Academy of Athens · GR

Funding

Large Scale Data Analysis for Brain ImagesR01MH068066 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI MEGALOOIKONOMOU, VASILEIOS · 2004 to 2007
$1.3M
NIMH NIH HHS R01 MH068066
6 · The paper itself

Abstract

At the end of the 1980s, the hepatitis C virus (HCV) was cloned and formally identified as the cause of the majority of non-A and non-B hepatitis cases. Today, around 170 million people worldwide are infected with HCV, making it five times more common than infection with the human immunodeficiency virus (HIV). Several methods exist which mediate the spread of infection. One of the most common and efficient is sharing or re-using injecting equipment; studies have indicated that 80-90% of individuals in some populations of intravenous drug users test positive in serum HCV assays. Contracting HCV from infected blood transfusions was also a major cause of infection before screening tests were introduced in the early 1990s. Other possible, but less common, methods of infection transmission include mother-to-child during pregnancy, sexual contact and nosocomial acquisition (for example between surgical or dialysis patients). It appears that concurrent HIV-1 infection increases the risk of HCV transmission via the mother-to-child or sexual routes.

Identifiers

PMID29387656
PMCPMC5788192
OpenAlexW2777669136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.